21 October 2016
With today's judgment the European Court of Justice ("ECJ") has ruled that the
German fixed price system for prescription-only medicinal products ("Rx products")
is incompatible with the principle of the free movement of goods under
European law. Although, consequences of the judgment will have to be assessed
in more detail, to avoid disadvantages for German dispensing pharmacies,
a more radical change of the current legal framework may be required.